Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Salarius Pharmaceuticals ...

    NASDAQ: SLRX · Real-Time Price · USD
    0.73
    -0.02 (-3.13%)
    At close: Jun 06, 2025, 3:58 PM
    0.72
    -1.55%
    After-hours: Jun 06, 2025, 04:00 PM EDT

    Salarius Pharmaceuticals Statistics

    Share Statistics

    Salarius Pharmaceuticals has 2.13M shares outstanding. The number of shares has increased by 192.39% in one year.

    Shares Outstanding

    n/a
    		 2.13M

    Shares Change (YoY)

    n/a
    		 192.39%

    Shares Change (QoQ)

    n/a
    		 21.13%

    Owned by Institutions (%)

    n/a
    		 6.11%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 6,774

    FTD / Avg. Volume

    n/a
    		 3.24%

    Short Selling Information

    The latest short interest is 52.65K, so 2.48% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 52.65K

    Short % of Shares Out

    n/a
    		 2.48%

    Short % of Float

    n/a
    		 2.49%

    Short Ratio (days to cover)

    n/a
    		 1.5

    Valuation Ratios

    The PE ratio is -0.32 and the forward PE ratio is -0.05. Salarius Pharmaceuticals's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.32

    Forward PE

    n/a
    		 -0.05

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 1.17

    P/FCF Ratio

    n/a
    		 -0.39

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Salarius Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.15.

    Current Ratio

    n/a
    		 1.98

    Quick Ratio

    n/a
    		 1.98

    Debt / Equity

    n/a
    		 0.15

    Debt / EBITDA

    n/a
    		 -0.04

    Debt / FCF

    n/a
    		 -0.05

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,787,888.5

    Employee Count

    n/a
    		 2

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -77.91% in the last 52 weeks. The beta is 0.4, so Salarius Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.4

    52-Week Price Change

    n/a
    		 -77.91%

    50-Day Moving Average

    n/a
    		 0.75

    200-Day Moving Average

    n/a
    		 1.39

    Relative Strength Index (RSI)

    n/a
    		 45.66

    Average Volume (20 Days)

    n/a
    		 209,071

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -5.73M

    Net Income

    n/a
    		 -5.58M

    EBITDA

    n/a
    		 -5.57M

    EBIT

    n/a
    		 -5.58M

    Earnings Per Share (EPS)

    n/a
    		 -5.79
    Full Income Statement

    Balance Sheet

    The company has 2.43M in cash and 221.87K in debt, giving a net cash position of 2.21M.

    Cash & Cash Equivalents

    n/a
    		 2.43M

    Total Debt

    n/a
    		 221.87K

    Net Cash

    n/a
    		 2.21M

    Retained Earnings

    n/a
    		 -81.92M

    Total Assets

    n/a
    		 2.34M

    Working Capital

    n/a
    		 722.18K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.53M and capital expenditures 0, giving a free cash flow of -4.53M.

    Operating Cash Flow

    n/a
    		 -4.53M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -4.53M

    FCF Per Share

    n/a
    		 -4.7
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SLRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SLRX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 17, 2024. It was a backward split with a ratio of 1:8.

    Last Split Date

    n/a
    		 Jun 17, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:8

    Scores

    Altman Z-Score

    n/a
    		 -57.24

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist